ADAMTS-BINDENDE IMMUNOGLOBULINE

Patent europeic · EP3630847 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3630847
Numer da la dumonda
EP18730689
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
04-06-2018
Publitgà
08-04-2020
Concedì
04-09-2024
La protecziun finescha il pli tard
03-06-2038
Proxima taxa annuala scadenta
30-06-2027
Classas IPC
C07K 16/40 (2006.01)
A61K 39/395 (2006.01)
A61P 19/02 (2006.01)
Prioritad
EP 17174403 02.06.2017
Dumonda PCT
PCT/EP2018/064665 04.06.2018
Publicaziun PCT
WO2018/220234 06.12.2018
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-07-2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. 16-07-2025

    Midada

    Published in Swissreg on 16.07.2025

  3. 01-07-2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  4. 30-10-2024

    Represchentant inscrit

    Representative
    Novartis Pharma AG, Patent Department, Lichtstrasse 35, 4056 Basel

    Published in Swissreg on 30.10.2024

  5. 04-09-2024

    Concedì

    Published in Swissreg on 04.09.2024

Partidas

Inventur

GUEHRING, Hans

65336 Geissenheim, DE

KELLNER, Roland

64646 Heppenheim, DE

BUYSE, Marie-Ange

9820 Merelbeke, BE

HERMANS, Guy

9820 Merelbeke, BE

GUENTHER, Ralf

64347 Griesheim, DE

LINDEMANN, Sven

64291 Darmstadt, DE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.